Pulmonary manifestations in Egyptian patients with systemic sclerosis-Reference-Cited by-同舟云学术

Pulmonary manifestations in Egyptian patients with systemic sclerosis

Published:2018-01 Issue:1 Volume:40 Page:39-44
ISSN:1110-1164
Container-title:The Egyptian Rheumatologist
language:en
Short-container-title:The Egyptian Rheumatologist

Author:

Hafez Eman A.,Hamza Sherin H.,Morad Caroline S.,Abd Alkader Ahmed A.

Publisher

Elsevier BV

Subject

Rheumatology

Reference31 articles.

1. Scleroderma lung disease;Solomon;Eur Respir Rev,2013

2. Lung involvement in systemic sclerosis;Nadkar;Med Update,2011

3. Pulmonary manifestation of scleroderma and mixed connective tissue disease;Hant;Clin Chest Med,2010

4. Causes and risk factors for death in systemic sclerosis: A study from the EULAR scleroderma trials and research (EUSTAR) database;Tyndall;Ann Rheum Dis,2010

5. Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis;Pope;J Rheumatol,2005

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum levels of angiotensin converting enzyme 2 in patients with systemic sclerosis;The Egyptian Rheumatologist;2024-04

2. Lung Imaging Perspective in Scleroderma;Scleroderma;2024

3. Molecular typing of HLA-class II alleles reveals an association with autoantibodies and disease subsets of systemic sclerosis in a North Indian (Kashmir) population;The Egyptian Rheumatologist;2023-06

4. Patterns of Interstitial Lung Disease in Egyptian Patients with Systemic Sclerosis: Relation to Disease Parameters;Current Rheumatology Reviews;2023-05

5. Krebs von den Lungen-6 (KL-6), soluble programmed cell death-1 (sPD-1) and its ligand-1(sPDL-1) in systemic sclerosis patients: Relation to disease parameters;The Egyptian Rheumatologist;2022-10